Similar articles

• Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.

  Blumenthal DK, Charbonneau H, Edelman AM, Hinds TR, Rosenberg GB, Storm DR, Vincenzi FF, Beavo JA, Krebs EG. Blumenthal DK, et al. Biochem Biophys Res Commun. 1988 Oct 31;156(2):860-5. doi: 10.1016/s0006-291x(88)80923-9. Biochem Biophys Res Commun. 1988. PMID: 2903735
• Estimating the association of phosphodiesterase with calmodulin in intact cells.

  Miller JR, Wells JN. Miller JR, et al. Methods Enzymol. 1988;159:594-604. doi: 10.1016/0076-6879(88)59057-2. Methods Enzymol. 1988. PMID: 2842622 No abstract available.
• Interaction of local anesthetics with calmodulin.

  Tanaka T, Hidaka H. Tanaka T, et al. Biochem Biophys Res Commun. 1981 Jul 30;101(2):447-53. doi: 10.1016/0006-291x(81)91280-8. Biochem Biophys Res Commun. 1981. PMID: 6272759 No abstract available.
• Novel and selective inhibitors of CaM-kinase II and other calmodulin-dependent enzymes.

  Hidaka H, Hagiwara M, Tokumitsu H. Hidaka H, et al. Adv Exp Med Biol. 1990;269:159-62. doi: 10.1007/978-1-4684-5754-4_26. Adv Exp Med Biol. 1990. PMID: 2162135 Review. No abstract available.
• Calmodulin.

  Cheung WY. Cheung WY. Sci Am. 1982 Jun;246(6):62-70. doi: 10.1038/scientificamerican0682-62. Sci Am. 1982. PMID: 6285461 Review. No abstract available.